2U3:FRA
Alcon AG
56,92 €
arrow_downward
-0,07%(-0,040) 1K
6-okt, 10:03:55 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto2U3 tikeri uchun statistika yaratilmoqda...
Ochish
56,50 €
Yuqori
56,92 €
Past
56,50 €
Bozor kapitali
26,52Â mlrd
Oʻrtacha hajm
210,00
Hajmi
34,00
52 haftalik eng yuqori
73,96 €
52 haftalik eng past
51,78 €
Xodimlar soni
25Â ming
Ochish
56,50 €
Yuqori
56,92 €
Past
56,50 €
Bozor kapitali
26,52Â mlrd
Oʻrtacha hajm
210,00
Hajmi
34,00
52 haftalik eng yuqori
73,96 €
52 haftalik eng past
51,78 €
Xodimlar soni
25Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
1 soat oldin
Jefferies keeps Buy rating on Alcon stock at USD 85 target
AD HOC NEWS
·
15 soat oldin
Alcon stock after-hours at EUR 57.18: plus 1.08 percent versus prior close
AD HOC NEWS
·
18 soat oldin
Alcon stock gets a new weekly lens launch in October 2026
AD HOC NEWS
·
22 soat oldin
Alcon announces Academy research. Alcon stock sits 23.02 percent below its 52-week high
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Alcon AG haqida
CEODavid J. Endicott
Xodimlar soni25Â ming
Asos solingan1945
Bosh ofislarJeneva, Geneva, Shveytsariya
Sektor-
Veb-saytalcon.com